Canine hyperadrenocorticism: Effects of trilostane on parathyroid hormone, calcium and phosphate concentrations

Journal of Small Animal Practice

Volumn 46, Issue 11, 2005, Pages 537-542

  Tebb, A J ^a,c   Arteaga, A ^a   Evans, H ^b   Ramsey, I K ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Peek House Business Centre   (United Kingdom)

^c MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROSTANOLONE; CALCIUM; DRUG DERIVATIVE; ENZYME INHIBITOR; PARATHYROID HORMONE; PHOSPHATE; TRILOSTANE;

ADRENAL CORTEX HYPERFUNCTION; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUPLING FACTOR; DOG; DOG DISEASE; DRUG ANTAGONISM; FEMALE; MALE; SECONDARY HYPERPARATHYROIDISM;

3-HYDROXYSTEROID DEHYDROGENASES; ADRENOCORTICAL HYPERFUNCTION; ANIMALS; CALCIUM; DIHYDROTESTOSTERONE; DOG DISEASES; DOGS; ENZYME INHIBITORS; FEMALE; HYPERPARATHYROIDISM, SECONDARY; MALE; OXIDATIVE PHOSPHORYLATION COUPLING FACTORS; PARATHYROID HORMONE; PHOSPHATES;

CANIS FAMILIARIS;

EID: 27744526211     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.2005.tb00283.x     Document Type: Article

References (32)

1. Au, W. Y. (1976) Cortisol stimulation of parathyroid hormone secretion by rat parathyroid glands in organ culture. Science 193, 1015-1017
2. CANALIS, E. & GIUSTINA, A. (2001) Glucocorticoid-induced osteoporosis: summary of a workshop. Journal of Clinical Endocrinology and Metabolism 86, 5681-5685
3. FAGGIANO, A., PIONELLO, R., MELIS, D., FILAPPELLA, M., DO SOMMA, C., PETRETTA, M., LOMBARDI, G. & COLAO, A. (2003) Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis and modification after disease cure. Journal of Clinical Endocrinology and Metabolism 22, 2076-2080
4. FELDMAN, E. C. & NELSON, R. W. (2004) Canine hyperadrenocorticism (Cushing's syndrome). In: Canine and Feline Endocrinology and Reproduction. 3rd edn. W. B. Saunders, Philadelphia. pp 252-357
5. FELDMAN, E. C., NELSON, R. W. & FELDMAN, M. S. (1996) Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs. Journal of the American Veterinary Medical Association 209, 772-775
6. FINDLING, J. W., ADAMS, N. D., LEMANN, J. J., GRAY, R. W., THOMAS, C. J. & TYRRELL, J. B. (1982) Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. Journal of Clinical Endocrinology and Metabolism 54, 1039-1044
7. FUCIK, R., KUKREJA, S. C., HARGIS, G. K., BOWSER, E. N., HENDERSON, W. J. & WILLIAMS, G. A. (1975) Effect of glucocorticoids on the function of parathyroid glands in man. Journal of Clinical Endocrinology and Metabolism 40, 152-155
8. GOULD, S. M., BAINES, E. A., MANNION, P. A., EVANS, H. & HERRTAGE, M. E. (2001) Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism. Journal of Small Animal Practice 42, 113-121
9. HAHN, T. J., HALSTEAD, L. R., TEITELBAUM, S. L. & HAHN, B. H. (1979) Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. Journal of Clinical Investigation 64, 655-665
10. HATTERSLEY, A. T., MEERAN, K., BURRIN, J., HILL, P., SHINER, R. & IBBERTSON, H. K. (1994) The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcified Tissue International 54, 198-202
11. HERRTAGE, M. E. (1998) Canine hyperadrenocorticism. In: Manual of Small Animal Endocrinology. 2nd edn. Eds A. G. Torrance and C. T. Mooney. BSAVA, Gloucester. pp 55-74
12. HERMUS, A. R., SMALS, A. G., SWINKELS, L. M., HUYSMANS, D. A., PIETERS, G. F., SWEEP, C. F., CORSTENS, F. H. & KLOPPENBORG, P. W. (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 80, 2859-2865
13. HESS, R. S., KASS, P. H. & WARD, C. R. (1998) Association between hyperadrenocorticism and development of calcium-containing uroliths in dogs with urolithiasis. Journal of the American Veterinary Medical Association 212, 1889-1891
14. HOERAUF, A. & REUSCH, C. (1999) Ultrasonographic characteristics of both adrenal glands in 15 dogs with functional adrenocortical tumors. Journal of the American Animal Hospital Association 35, 193-199
15. HOWLAND, W., PUGH, D. & SPRAGUE, R. (1958) Roent-genolic changes of the skeletal system in Cushing's syndrome. Radiology 71, 69-78
16. KUGAI, N., KOIDE, Y., YAMASHITA, K., SHIMAUCHI, T., NAGATA, N. & TAKATANI, O. (1986) Imparted mineral metabolism in Cushing's syndrome: parathyroid function, vitamin D metabolites and osteopenia. Endocrinologia Japonica 33, 353-359
17. LÓPEZ, I., AGUILERA-TEJERO, E., ESTEPA, J. C., BAS, S., MAYER-VALOR, R., JIMÉNEZ, A. & RODRÍGUEZ, M. (2005) Diurnal variations in the plasma concentration of parathyroid hormone in dogs. Veterinary Record 157, 344-347
18. LUKERT, B. P. & ADAMS, J. S. (1976) Calcium and phosphorus homeostasis in man. Effects of corticosteroids. Archives of Internal Medicine 13, 1249-1253
19. MANELLI, F., BOSSONI, S., BUGARI, G., CARPINTERI, R., GODI, D., ROSEEI, A. E., VELDHUIS, J. D. & GIUSTINA, A. (2001) Chronic glucocorticoid treatment alters the spontaneous pulsatile parathyroid hormone (PTH) secretory pattern in humans. Proceedings of the 83rd Annual Meeting of the Endocrinology Society, Denver. p 125
20. MANNING, P., EVANS, M. & REID, I. (1992) Normal bone mineral density following cure of Cushing's syndrome. Clinical Endocrinology 36, 229-234
21. OHMORI, N., NOMURA, K., OHMORI K., KATO, Y., ITOH, T. & TAKANO, K. (2003) Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome. Endocrine Journal 50, 1-7
22. PETERSON, M. E. (1984) Hyperadrenocorticism. Veterinary Clinics of North America: Small Animal Practice 14, 731-749
23. RAMSEY, I. K. & HERRTAGE, M. E. (2001) Increased parathyroid hormone concentrations in dogs with hyperadrenocorticism. Journal of Veterinary Internal Medicine 15, 298
24. RAMSEY, I. K., TEBB, A., HARRIS, E., EVANS, H. & HERRTAGE, M. E. (2005) Hyperparathyroidism in dogs with hyperadrenocorticism. Journal of Small Animal Practice 46, 351-356
25. RODRIGUEZ, M., ALMADEN, Y., HERNANDEZ, A. & TORRES, A. (1996) Effect of phosphate on the parathyroid gland: direct and indirect? Current Opinion in Nephrology and Hypertension 5, 321-328
26. RUBIN, M. R. & BILEZIKIAN, J. P. (2002) Clinical review 151: the role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. Journal of Clinical Endocrinology and Metabolism 87, 4033-4041
27. SCHMITT, C. P., SCHAEFER, F., BRUNCH, A., VELDUIS, J. D., SCHMITT-GAYK, H., STEIN, G., RITZ, E. & MEHLS, O. (1996) Control of pulsatile and tonic parathyroid hormone secretion by ionised calcium. Journal of Clinical Endocrinology and Metabolism 81, 4236-4243
28. SCHWARZ, T., STORK, C. K., MELLOR, D. & SULLIVAN, M. (2000) Osteopenia and other radiographic signs in canine hyperadrenocorticism. Journal of Small Animal Practice 41, 491-495
29. STURGEON, C., BARBER, P. J. & ELLIOTT, J. (1995) The effect of hyperadrenocorticism and high dose glucocorticoid therapy on parathyroid hormone secretion in the dog. BSAVA Congress Proceedings, Birmingham. April 6 to 9, 1995. p 252
30. SUZUKI, Y., ICHIKAWA, Y., SAITO, E. & HOMMA, M. (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism: Clinical and Experimental 32, 151-156
31. TORRANCE, A. G. & NACHREINER, R. (1989) Human-parathormone assay for use in dogs: validation, sample handling studies, and parathyroid function testing. American Journal of Veterinary Research 50, 1123-1127
32. WILLIAMS, G. A., BOWSER, E. N., HENDERSON, W. J. & RAND, S. (1969) Journal of Laboratory Clinical Medicine 74, 1023